Who will receive COVID-19 vaccines first?

EPR ’s Hannah Balfour discusses some of the proposed COVID-19 vaccine distribution plans and how medicinal nationalism and supply deals could prevent “fair and equitable access” to COVID-19 vaccines. There are currently five investigational COVID-19 vaccines undergoing Phase III clinical trials globally, with several other potential candidates in earlier […]

Click here to view original web page at www.europeanpharmaceuticalreview.com